Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Miguel Martin

1-50 of 110 results

View this query on the Wikidata Query Service
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.

scientific article
Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.

scientific article published on 09 February 2009
Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer.

scientific article published on 20 September 2010
The global breast cancer burden: variations in epidemiology and survival.

scientific article
PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.

scientific article
Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast Cancer

scientific article published on 02 July 2007
Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial.

scientific article published in March 2003
Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.

scientific article
Final overall survival: fulvestrant 500 mg vs 250 mg in the randomized CONFIRM trial

scientific article published on 07 December 2013
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer

scientific article
Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active th

scientific article
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis

scientific article
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.

scientific article
Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.

scientific article published on December 2012
Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer

scientific article published on 14 May 2011
Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial

scientific article
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial

scientific article published on 10 December 2012
Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study.

scientific article published on 17 February 2015
Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31.

scientific article published on 16 March 2015
Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

scientific article published on 01 March 2007
A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer

scientific article published on August 15, 2013
Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study.

scientific article published on July 2004
Docetaxel-related side effects and their management

scientific article published on 07 February 2009
Primary results of ROSE/TRIO-12, a randomized placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer.

scientific article
A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS

scientific article
Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study

scientific article
Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case-control EpiGEICAM study

scientific article
Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.

scientific article published on 16 January 2014
Bone-related complications and quality of life in advanced breast cancer: results from a randomized phase III trial of denosumab versus zoledronic acid

scientific article published on 14 August 2012
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer

scientific article published on 20 February 2013
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.

scientific article
Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer

scientific article published on 6 October 2014
Maintenance treatment with pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study.

scientific article published on 2 April 2010
Estrogen receptor expression and efficacy of docetaxel-containing adjuvant chemotherapy in patients with node-positive breast cancer: results from a pooled analysis.

scientific article published in June 2008
A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome

scientific article published on 16 February 2011
Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study

scientific article published on 03 June 2013
Assessment of Topoisomerase II α status in breast cancer by quantitative PCR, gene expression microarrays, immunohistochemistry, and fluorescence in situ hybridization

scientific article
PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance

scientific article published on 3 February 2015
Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis

scientific article
Trastuzumab associated with successive cytotoxic therapies beyond disease progression in metastatic breast cancer.

scientific article published in October 2005
BCIRG 001 molecular analysis: prognostic factors in node-positive breast cancer patients receiving adjuvant chemotherapy.

scientific article published on 24 June 2010
Circulating tumor cells in solid tumor in metastatic and localized stages

scientific article published on 01 November 2009
Incidence-based cost-of-illness model for metastatic breast cancer in the United States.

scientific article published in January 2012
Docetaxel-containing adjuvant chemotherapy in patients with early stage breast cancer. Consistency of effect independent of nodal and biomarker status: a meta-analysis of 14 randomized clinical trials

scientific article published on 24 January 2012
Running away from side effects: physical exercise as a complementary intervention for breast cancer patients.

scientific article published on 04 June 2014
Recent advances in systemic therapy: advances in adjuvant systemic chemotherapy of early breast cancer.

scientific article published on 19 March 2009
Denosumab for the treatment of bone metastases in advanced breast cancer.

scientific article published on 04 June 2013
Characterization of uncertainty in the classification of multivariate assays: application to PAM50 centroid-based genomic predictors for breast cancer treatment plans.

scientific article published on 23 December 2011
Benefit from adjuvant taxanes and endocrine responsiveness in breast cancer.

scientific article published on 17 October 2007
The evolving landscape of protein kinases in breast cancer: clinical implications.

scientific article published on 15 June 2012

Paulina is supported by:

About Paulina

Help